| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2003;125:261-272
© 2003 The American Association for Thoracic Surgery
General Thoracic Surgery (GTS) |
From the Division of Cardiothoracic Surgery, University of Washington, Seattle, Wash.
Received for publication May 31, 2002. Revisions requested July 11, 2002; revisions received July 25, 2002. Accepted for publication Aug 6, 2002. Address for reprints: Michael S. Mulligan, MD, Division of Cardiothoracic Surgery, University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195 (E-mail: msmmd{at}u.washington.edu).
Objective: Proinflammatory cytokines are known to play roles in ischemia-reperfusion injury of the heart, kidney, small bowel, skin, and liver. Little is known about their roles in ischemia-reperfusion injury of the lung. This study was undertaken to define the role of 2 proinflammatory cytokines, tumor necrosis factor 
and interleukin 1ß, in ischemia-reperfusion injury of the lung.
Methods: Left lungs of male rats were rendered ischemic for 90 minutes and reperfused for up to 4 hours. Treated animals received anti-tumor necrosis factor or anti-interleukin 1ß antibody before reperfusion. Increased vascular permeability in the lung was measured by using iodine 125-labeled bovine serum albumin. Neutrophil sequestration in the lung parenchyma was determined on the basis of activity. Bronchoalveolar lavage was performed to measure cell counts. Separate tissue samples were processed for histology, cytokine protein, and messenger RNA content by using Western blotting and the ribonuclease protection assay.
Results: Animals receiving anti-tumor necrosis factor and anti-interleukin 1ß demonstrated reduced injury compared with that seen in positive control animals (vascular permeability of 48.7% and 29.4% lower, respectively; P < .001). Vascular injury was reduced by 71% when antibodies to tumor necrosis factor and interleukin 1ß were administered together. Lung neutrophil accumulation was markedly reduced among animals receiving anti-tumor necrosis factor and anti-interleukin 1ß (myeloperoxidase content of 30.9% and 38.5% lower, respectively; P < .04) and combination blockade afforded even greater protection (52.4% decrease, P < .01). Bronchoalveolar lavage leukocyte content was also reduced by treatment with anti-tumor necrosis factor , anti-interleukin 1ß, and combination treatment. Reductions in permeability, myeloperoxidase, and bronchoalveolar lavage leukocyte content also resulted in a decrease in a histologic injury. Finally, anti-tumor necrosis factor and anti-interleukin 1ß treatment resulted in decreased messenger RNA expression for a number of early response and regulatory cytokines.
Conclusion: Tumor necrosis factor and interleukin 1ß help regulate the development of lung ischemia-reperfusion injury. They appear to promote injury by altering expression of proinflammatory and anti-inflammatory cytokines and influencing tissue neutrophil recruitment.
This article has been cited by other articles:
|
|
 |
|
  W. Qiu, L. Zheng, H. Gu, D. Chen, and Y. Chen Comparison between adult and infant lung injury in a rabbit ischemia-reperfusion model. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 352 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Wolf, H. E. Merry, A. S. Farivar, A. S. McCourtie, and M. S. Mulligan Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 656 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Mussi, E. A. Camargo, T. Ferreira, C. De Moraes, M. A. Delbin, I. F. C. Toro, S. Brancher, E. C. T. Landucci, A. Zanesco, and E. Antunes Exercise training reduces pulmonary ischaemia-reperfusion-induced inflammatory responses Eur. Respir. J., March 1, 2008; 31(3): 645 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Gazoni, C. G. Tribble, M. Q. Zhao, E. B. Unger, R. A. Farrar, P. I. Ellman, L. G. Fernandez, V. E. Laubach, and I. L. Kron Pulmonary Macrophage Inhibition and Inhaled Nitric Oxide Attenuate Lung Ischemia-Reperfusion Injury Ann. Thorac. Surg., July 1, 2007; 84(1): 247 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Sharma, L. G. Fernandez, A. S. Awad, I. L. Kron, and V. E. Laubach Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-{alpha} during pulmonary ischemia-reperfusion injury Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L105 - L113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Van De Wauwer, A. P. Neyrinck, N. Geudens, F. R. Rega, G. M. Verleden, E. Verbeken, T. E. Lerut, and D. E.M. Van Raemdonck Retrograde flush following topical cooling is superior to preserve the non-heart-beating donor lung Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1125 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhao, L. G. Fernandez, A. Doctor, A. K. Sharma, A. Zarbock, C. G. Tribble, I. L. Kron, and V. E. Laubach Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1018 - L1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Farivar, H. E. Merry, M. J. Fica-Delgado, A. S. McCourtie, B. C. Mackinnon-Patterson, and M. S. Mulligan Interleukin-6 Regulation of Direct Lung Ischemia Reperfusion Injury Ann. Thorac. Surg., August 1, 2006; 82(2): 472 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Varghese Jr Invited commentary Ann. Thorac. Surg., August 1, 2006; 82(2): 478 - 479. [Full Text] [PDF]
|
|
|
|
|
|
A. S. Farivar, M. F. Delgado, A. S. McCourtie, A. D. Barnes, E. D. Verrier, and M. S. Mulligan Crosstalk Between Thrombosis and Inflammation in Lung Reperfusion Injury. Ann. Thorac. Surg., March 1, 2006; 81(3): 1061 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Wilkes, T. M. Egan, and H. Y. Reynolds Lung Transplantation: Opportunities for Research and Clinical Advancement Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 944 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shimoyama, N. Tabuchi, K. Kojima, H. Akamatsu, H. Arai, H. Tanaka, and M. Sunamori Aprotinin attenuated ischemia-reperfusion injury in an isolated rat lung model after 18-hours preservation Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 581 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liu, P. Drew, Y. Cheng, and G. A. Visner Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 852 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Reece, P. I. Ellman, T. S. Maxey, I. K. Crosby, P. S. Warren, T. W. Chong, R. D. LeGallo, J. Linden, J. A. Kern, C. G. Tribble, et al. Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1137 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Goto, A. Ishizaka, F. Kobayashi, M. Kohno, M. Sawafuji, S. Tasaka, E. Ikeda, Y. Okada, I. Maruyama, and K. Kobayashi Importance of Tumor Necrosis Factor-{alpha} Cleavage Process in Post-Transplantation Lung Injury in Rats Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1239 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Farivar, S. M. Woolley, C. H. Fraga, R. Thomas, A. L. Salzman, C. Szabo, and M. S. Mulligan Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury Ann. Thorac. Surg., June 1, 2004; 77(6): 1938 - 1943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Waldow, K. Alexiou, W. Witt, F. M. Wagner, V. Gulielmos, K. Matschke, and M. Knaut Attenuation of Reperfusion-Induced Systemic Inflammation by Preconditioning With Nitric Oxide in an In Situ Porcine Model of Normothermic Lung Ischemia Chest, June 1, 2004; 125(6): 2253 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Krishnadasan, A. S. Farivar, B. V. Naidu, S. M. Woolley, K. Byrne, C. H. Fraga, and M. S. Mulligan {beta}-chemokine function in experimental lung ischemia-reperfusion injury Ann. Thorac. Surg., March 1, 2004; 77(3): 1056 - 1062. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
